Mitsumasa Ogawara

1.3k total citations
50 papers, 1.0k citations indexed

About

Mitsumasa Ogawara is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Mitsumasa Ogawara has authored 50 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 26 papers in Pulmonary and Respiratory Medicine and 19 papers in Molecular Biology. Recurrent topics in Mitsumasa Ogawara's work include Lung Cancer Research Studies (22 papers), Lung Cancer Treatments and Mutations (14 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Mitsumasa Ogawara is often cited by papers focused on Lung Cancer Research Studies (22 papers), Lung Cancer Treatments and Mutations (14 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Mitsumasa Ogawara collaborates with scholars based in Japan, United Kingdom and Uzbekistan. Mitsumasa Ogawara's co-authors include Kiyoyuki Furuse, Mutsuto Kawahara, Saburo Sone, M Takada, Shunichi Negoro, N Masuda, Nobuhiro Kodama, Kaoru Kubota, Teruhiro Utsugi and Masaaki Kawahara and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer.

In The Last Decade

Mitsumasa Ogawara

46 papers receiving 978 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsumasa Ogawara Japan 18 571 506 257 168 133 50 1.0k
Shinjiro Sakamoto Japan 16 331 0.6× 428 0.8× 135 0.5× 89 0.5× 162 1.2× 98 838
T Ohnoshi Japan 14 308 0.5× 159 0.3× 192 0.7× 200 1.2× 100 0.8× 92 721
Georg Pall Austria 17 362 0.6× 195 0.4× 161 0.6× 75 0.4× 166 1.2× 49 811
Shogo Kumagai Japan 15 450 0.8× 389 0.8× 216 0.8× 177 1.1× 254 1.9× 37 1.0k
Viswanath Reddy Belum United States 17 649 1.1× 140 0.3× 208 0.8× 160 1.0× 95 0.7× 25 1.1k
Timothy J. O’Rourke United States 15 345 0.6× 210 0.4× 311 1.2× 87 0.5× 70 0.5× 34 962
Nanette McAtee United States 12 377 0.7× 169 0.3× 241 0.9× 128 0.8× 206 1.5× 16 1.0k
Priscila Gonçalves United States 19 800 1.4× 157 0.3× 330 1.3× 244 1.5× 136 1.0× 47 1.3k
Timothy Aliff United States 8 908 1.6× 1.0k 2.0× 282 1.1× 187 1.1× 68 0.5× 8 1.6k
Daniel L. Kisner United States 13 221 0.4× 135 0.3× 284 1.1× 113 0.7× 173 1.3× 32 928

Countries citing papers authored by Mitsumasa Ogawara

Since Specialization
Citations

This map shows the geographic impact of Mitsumasa Ogawara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsumasa Ogawara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsumasa Ogawara more than expected).

Fields of papers citing papers by Mitsumasa Ogawara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsumasa Ogawara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsumasa Ogawara. The network helps show where Mitsumasa Ogawara may publish in the future.

Co-authorship network of co-authors of Mitsumasa Ogawara

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsumasa Ogawara. A scholar is included among the top collaborators of Mitsumasa Ogawara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsumasa Ogawara. Mitsumasa Ogawara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kubota, Kaoru, Masaaki Kawahara, Mitsumasa Ogawara, et al.. (2008). Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study. The Lancet Oncology. 9(12). 1135–1142. 64 indexed citations
2.
Watanabe, Yoshihiro, Mark Elliott, Heather Secrist, et al.. (2006). Characterization of preexisting humoral immunity specific for two cancer-testis antigens overexpressed at the mRNA level in non-small cell lung cancer.. PubMed. 6. 3–3. 9 indexed citations
3.
Hirai, Kei, et al.. (2005). Outpatient Chemotherapy Decision-making in Lung Cancer. Haigan. 45(2). 105–110. 4 indexed citations
4.
Atagi, Shinji, Masaaki Kawahara, Shigeto Hosoe, et al.. (2002). A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer. Lung Cancer. 36(1). 105–111. 6 indexed citations
5.
Ogawara, Mitsumasa. (2002). A Feasibility Study of Paclitaxel 225 mg/m2 and Carboplatin AUC = 6 in Untreated Advanced Non-small Cell Lung Cancer Patients in Japan. Japanese Journal of Clinical Oncology. 32(2). 48–53. 9 indexed citations
6.
Kawaguchi, Tomoko, Kyoichi Okishio, Kiyonobu Ueno, et al.. (2000). [Autopsy case of adenoid cystic carcinoma of the trachea: endobronchial treatment improves quality of life].. PubMed. 38(10). 812–6. 1 indexed citations
7.
Furuse, Kiyoyuki, et al.. (1999). A Case of Long-term Survival with Stage IV Small Cell Lung Cancer and Early-stage Central-type Squamous Cell Lung Cancer Treated by Photodynamic Therapy. Japanese Journal of Clinical Oncology. 29(1). 45–48. 3 indexed citations
8.
Ogawara, Mitsumasa & Miki Sakatani. (1998). [Multidrug-resistant tuberculosis. 4. Treatment and prognosis of multidrug-resistant tuberculosis].. PubMed. 73(11). 673–7. 1 indexed citations
9.
Matsui, K, N Masuda, M. Fukuoka, et al.. (1998). Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer. British Journal of Cancer. 77(11). 1961–1965. 39 indexed citations
10.
Fukuoka, M., N Masuda, Shunichi Negoro, et al.. (1997). CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer. British Journal of Cancer. 75(2). 306–309. 37 indexed citations
11.
Atagi, Shinji, Kiyoyuki Furuse, Mutsuto Kawahara, et al.. (1997). 538 Phase II trial of daily low-dose carboplatin (CBDCA) and radiotherapy (RT) in elderly patients with unresectable locally advanced non-small cell lung cancer (NSCLC). Lung Cancer. 18. 138–138. 2 indexed citations
12.
Furuse, Kiyoyuki, Mutsuto Kawahara, Nobuhiro Kodama, et al.. (1997). A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplatin, vindesine and mitomycin in non-small-cell lung cancer with brain metastasis. British Journal of Cancer. 75(4). 614–618. 22 indexed citations
13.
Matsui, Kaoru, Noriyuki Masuda, Yasuo Uchida, et al.. (1996). Determinants of Myelosuppression in the Treatment of Non‐small Cell Lung Cancer with Cisplatin‐containing Chemotherapy. Japanese Journal of Cancer Research. 87(7). 781–786. 6 indexed citations
14.
Furuse, Kiyoyuki, Kaoru Kubota, Mutsuto Kawahara, et al.. (1995). Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer. Southern Osaka Lung Cancer Study Group.. Journal of Clinical Oncology. 13(4). 869–875. 49 indexed citations
15.
Kawahara, Masaaki, et al.. (1995). Endobronchial Electrocautery Using Snare. Diagnostic and therapeutic endoscopy. 2(4). 207–210. 3 indexed citations
16.
17.
Fukuoka, Masahiro, Noriyuki Masuda, Shunichi Negoro, et al.. (1991). A phase I study of chronic daily dosing of oral etoposide in combination with cisplatin for patients with advanced cancer. Cancer. 68(2). 284–288. 8 indexed citations
18.
Kawahara, Masaaki, et al.. (1989). Use of sialyl SSEA-1(SLX) in adenocarcinoma of the lung.. Haigan. 29(4). 351–357. 1 indexed citations
19.
Kubota, Kaoru, et al.. (1989). Five-year-survival of small cell lung carcinoma.. Haigan. 29(2). 133–139. 1 indexed citations
20.
Kodama, Nobuhiro, et al.. (1988). [Combination chemotherapy of CDDP and etoposide in advanced non-small cell carcinoma of the lung].. PubMed. 15(12). 3233–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinjiro Sakamoto Breakdown of academic impact, for papers by T Ohnoshi Breakdown of academic impact, for papers by Georg Pall Breakdown of academic impact, for papers by Shogo Kumagai Breakdown of academic impact, for papers by Viswanath Reddy Belum Breakdown of academic impact, for papers by Timothy J. O’Rourke Breakdown of academic impact, for papers by Nanette McAtee Breakdown of academic impact, for papers by Priscila Gonçalves Breakdown of academic impact, for papers by Timothy Aliff Breakdown of academic impact, for papers by Daniel L. Kisner
Rankless by CCL
2026